Kharkiv National Medical University, formerly known as Kharkiv Medical Institute and previously Kharkiv State Medical University, is a medical university in Kharkiv, Ukraine. In March 2022 many buildings were heavily damaged due to the Russian invasion into Ukraine.

During the past decade, Municipal Noncommercial Institution Regional Center of Oncology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Municipal Noncommercial Institution Regional Center of Oncology" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Municipal Noncommercial Institution Regional Center of Oncology" are "Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials), "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Municipal Noncommercial Institution Regional Center of Oncology" in a lesser frequency.

Most popular intervention types in "Municipal Noncommercial Institution Regional Center of Oncology" are "Drug" (7 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Cyclophosphamide" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Municipal Noncommercial Institution Regional Center of Oncology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Municipal Noncommercial Institution Regional Center of Oncology". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Municipal Noncommercial Institution Regional Center of Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Municipal Noncommercial Institution Regional Center of Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Municipal Noncommercial Institution Regional Center of Oncology has several departments that took part in Clinical trials: "Chair of Psychiatry and Medical Psychology" - 4 trials, "Municipal Institution Regional hospital-center of emergency care and disasters medicine" - 4 trials, "State Institution Institute of therapy named after L.T.Malaya AMS Ukraine" - 3 trials, "Institute of Neruology, Nat Acad of Med Sci of UKR" - 2 trials, "Regional Clinical Psychiatric Hospital No. 3, Adult Psychiatric Department No. 3" - 2 trials, "Pulmonological and Allergological Department of the Kharkov Regional Clinical Hospital" - 2 trials